Showing results (201-210 of 255) with videos related to
Sort By:
Pageof 26
Cancer|December 6, 2002
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective studyGherardo Mazziotti, Francesca Sorvillo, Filomena Morisco, et al.Endocrine|April 16, 2024
Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpointPierpaolo Trimboli, Joerg Bojunga, Maurilio Deandrea, et al.Journal of Immunology Research|November 30, 2019
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous NephropathyGiuseppe Stefano Netti, Barbara Infante, Federica Spadaccino, et al.Endocrine Connections|March 29, 2017
Thyroid function in children and adolescents with Hashimoto's thyroiditis after l-thyroxine discontinuationGiorgio Radetti, Mariacarolina Salerno, Chiara Guzzetti, et al.Frontiers in Neurology|April 27, 2019
Fatigue in Multiple Sclerosis: General and Perceived Fatigue Does Not Depend on Corticospinal Tract DysfunctionLaura Mordillo-Mateos, Vanesa Soto-Leon, Marta Torres-Pareja, et al.Thyroid : Official Journal of the American Thyroid Association|May 23, 2013
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statementFrederik A Verburg, Markus Luster, Cristina Cupini, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cellsAdriana Lombardi, Giulia Cantini, Elisabetta Piscitelli, et al.Clinical Endocrinology|April 18, 2007
Genetic analysis of the PAX8 gene in children with congenital hypothyroidism and dysgenetic or eutopic thyroid glands: identification of a novel sequence variantMassimo Tonacchera, Maria Elena Banco, Lucia Montanelli, et al.Journal of Endocrinological Investigation|October 8, 2025
Effects of 6-month treatment with the GLP-1 receptor agonist liraglutide on 24-hour energy metabolism and body composition in adults with obesityAlessio Basolo, Giordano Paolucci, Paolo Piaggi, et al.The Journal of Clinical Endocrinology and Metabolism|January 20, 2005
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokinesMario Rotondi, Alberto Falorni, Annamaria De Bellis, et al.Pageof 26